• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

GRN No. 265

Substance: Glycerophospholipid cholesterol acyltransferase (GCAT) enzyme preparation from Bacillus licheniformis expressing a modified GCAT gene from Aeromonas salmonicida subsp. salmonicida
Intended Use: As an enzyme to modify phospholipids to lyso-phospholipids and cholesterol ester in egg yolks to avoid product separation during mayonnaise production; processed meat products for emulsification, better consistency, and reduced cooking loss; cheese for increased yield; eggs to give a softer and more tender crumb in bakery products, and degumming of vegetable oils

As an enzyme in the production of ultra-high temperature processed milk, powdered milk, and yogurt at concentrations ranging from 0.38 to 1.5 milligrams total organic solids per kilogram of food
Basis: Scientific procedures
Notifier: Genencor, a Danisco Division
Genencor, a Danisco Division
925 Page Mill Road
Palo Alto, CA 94304
Date of filing: Nov 7, 2008
GRAS Notice (releasable information): 265
Date of closure / FDA's Letter: Jun 13, 2009
FDA has no questions (additional correspondence available)
Additional correspondence: Additional correspondence about intended use: July 15, 2010
-
-